Form 8-K - Current report:
SEC Accession No. 0000950170-23-071563
Filing Date
2023-12-19
Accepted
2023-12-19 17:00:08
Documents
12
Period of Report
2023-12-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K tcon-20231213.htm   iXBRL 8-K 35479
  Complete submission text file 0000950170-23-071563.txt   148333

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcon-20231213.xsd EX-101.SCH 2481
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcon-20231213_lab.xml EX-101.LAB 12798
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcon-20231213_pre.xml EX-101.PRE 9461
6 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20231213_htm.xml XML 4550
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

EIN.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 231498227
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)